BLFS
Price
$22.60
Change
+$0.40 (+1.80%)
Updated
Oct 11 closing price
26 days until earnings call
GH
Price
$21.40
Change
+$0.79 (+3.83%)
Updated
Oct 11 closing price
19 days until earnings call
Ad is loading...

BLFS vs GH

Header iconBLFS vs GH Comparison
Open Charts BLFS vs GHBanner chart's image
BioLife Solutions
Price$22.60
Change+$0.40 (+1.80%)
Volume$384.45K
CapitalizationN/A
Guardant Health
Price$21.40
Change+$0.79 (+3.83%)
Volume$1.39M
CapitalizationN/A
View a ticker or compare two or three
BLFS vs GH Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BLFS vs. GH commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Sell and GH is a Hold.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (BLFS: $22.60 vs. GH: $21.40)
Brand notoriety: BLFS: Not notable vs. GH: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 118% vs. GH: 61%
Market capitalization -- BLFS: $810.87M vs. GH: $2.46B
BLFS [@Medical Specialties] is valued at $810.87M. GH’s [@Medical Specialties] market capitalization is $2.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileGH’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • GH’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 3 TA indicator(s) are bullish.

  • BLFS’s TA Score: 3 bullish, 5 bearish.

Price Growth

BLFS (@Medical Specialties) experienced а -7.91% price change this week, while GH (@Medical Specialties) price change was -3.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

GH is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than BLFS($811M). BLFS YTD gains are higher at: 39.077 vs. GH (-20.887). BLFS has higher annual earnings (EBITDA): -45.24M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. BLFS (51.7M). BLFS has less debt than GH: BLFS (42.7M) vs GH (1.35B). GH has higher revenues than BLFS: GH (564M) vs BLFS (143M).
BLFSGHBLFS / GH
Capitalization811M2.47B33%
EBITDA-45.24M-433.3M10%
Gain YTD39.077-20.887-187%
P/E Ratio238.10N/A-
Revenue143M564M25%
Total Cash51.7M1.17B4%
Total Debt42.7M1.35B3%
FUNDAMENTALS RATINGS
BLFS vs GH: Fundamental Ratings
BLFS
GH
OUTLOOK RATING
1..100
7853
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
4365
P/E GROWTH RATING
1..100
23100
SEASONALITY SCORE
1..100
950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (76) in the Medical Or Nursing Services industry is in the same range as BLFS (94) in the Medical Specialties industry. This means that GH’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew similarly to GH’s over the last 12 months.

BLFS's SMR Rating (94) in the Medical Specialties industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew similarly to GH’s over the last 12 months.

BLFS's Price Growth Rating (43) in the Medical Specialties industry is in the same range as GH (65) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew similarly to GH’s over the last 12 months.

BLFS's P/E Growth Rating (23) in the Medical Specialties industry is significantly better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that BLFS’s stock grew significantly faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFS
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X62445.0900002170.586000
+3.60%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+1.80%
AZTA - BLFS
51%
Loosely correlated
+2.00%
MASS - BLFS
51%
Loosely correlated
+4.52%
VCYT - BLFS
50%
Loosely correlated
+5.42%
RGEN - BLFS
50%
Loosely correlated
+3.22%
RDNT - BLFS
47%
Loosely correlated
+5.52%
More